New approach aims to make repeat radiation safer for cancer patients

NCT ID NCT05301101

Recruiting now Knowledge-focused Sponsor: Medical College of Wisconsin Source: ClinicalTrials.gov ↗

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This study looks at a standardized method for giving high-dose radiation a second time to people with solid tumors that have come back. It uses advanced imaging to better calculate radiation doses to sensitive organs like the spinal cord and gut. The goal is to track how often severe side effects occur and improve safety for future patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Re-irradiation (radiation therapy)
What this could lead to: If successful, this could establish safer, more precise re-irradiation methods for patients with recurrent solid tumors, potentially reducing severe side effects.
What could go wrong: This is an observational analysis, not a treatment trial, so it won't directly prove a new therapy works. Results may not apply to all tumor types or radiation techniques.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR

Contacts and locations

Locations

Froedtert Hospital
RECRUITING

Milwaukee, Wisconsin, 53226, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.